文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

埃及 EQ-5D-5L 广泛试点研究:经验教训。

The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned.

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo, 11562, Egypt.

EuroQol Research Foundation, Rotterdam, The Netherlands.

出版信息

Pharmacoeconomics. 2023 Mar;41(3):329-338. doi: 10.1007/s40273-022-01208-9. Epub 2022 Nov 25.


DOI:10.1007/s40273-022-01208-9
PMID:36434416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9928797/
Abstract

OBJECTIVES: To investigate the effect of an extensive pilot phase in improving protocol compliance, face validity, reduction of interviewer effect and prediction errors in the composite time trade-off (cTTO) data elicited as part of the EQ-5D-5L valuation study in Egypt. METHODS: This study used the cTTO data and quality control (QC) reports from the Egyptian EQ-5D-5L valuation study. Three-level mixed models were estimated to test whether interviewer effects were reduced during the pilot phase and subsequent rounds of collected cTTO data. Ordinary least square (OLS) regression analysis was conducted for each interviewer separately to test whether the mean absolute error (MAE) improved as interviewers completed more interviews. Moreover, improvement in protocol compliance, face validity and reduction of prediction errors in the cTTO data were tested. RESULTS: 1180 interviews were conducted by nine interviewers and included in the final analysis, of which 206 interviews were pilot and 974 interviews were actual. There was substantial improvement in the face validity and reduction of prediction errors in the cTTO data where the MAE of the actual data was 0.37, which is much lower than that of the pilot data, which was 0.44. However, there was an initial high level of protocol compliance in terms of the four indicators of the QC tool and the variance attributed to the interviewers was small throughout the whole study. CONCLUSIONS: This study clarified the benefits of the pilot phase and the strict implementation of the QC tool in improving the face validity and the prediction accuracy of the cTTO data. However, a more extensive pilot phase may be more beneficial in EQ-5D-5L valuation studies that have issues initially with protocol compliance and interviewer effects.

摘要

目的:研究广泛的试点阶段对提高复合时间权衡(cTTO)数据的方案依从性、表面有效性、减少访谈者效应和预测误差的影响,该数据是埃及 EQ-5D-5L 估值研究的一部分。

方法:本研究使用了埃及 EQ-5D-5L 估值研究的 cTTO 数据和质量控制(QC)报告。采用三级混合模型来检验在试点阶段和随后收集的 cTTO 数据的轮次中,访谈者效应是否减少。对每位访谈者分别进行普通最小二乘(OLS)回归分析,以检验随着访谈者完成更多访谈,平均绝对误差(MAE)是否得到改善。此外,还测试了 cTTO 数据的方案依从性、表面有效性和预测误差的减少。

结果:9 名访谈者共进行了 1180 次访谈,其中 206 次为试点访谈,974 次为实际访谈,最终纳入分析。cTTO 数据的表面有效性和预测误差都有显著改善,实际数据的 MAE 为 0.37,明显低于试点数据的 0.44。然而,QC 工具的四个指标在方案依从性方面的初始水平很高,并且整个研究过程中访谈者的方差很小。

结论:本研究阐明了试点阶段和严格执行 QC 工具在提高 cTTO 数据的表面有效性和预测准确性方面的益处。然而,在 EQ-5D-5L 估值研究中,对于最初在方案依从性和访谈者效应方面存在问题的研究,更广泛的试点阶段可能更有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/644a7f12f852/40273_2022_1208_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/aa4fb9fb88c0/40273_2022_1208_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/5c0cd9b7e461/40273_2022_1208_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/01521231be5e/40273_2022_1208_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/644a7f12f852/40273_2022_1208_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/aa4fb9fb88c0/40273_2022_1208_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/5c0cd9b7e461/40273_2022_1208_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/01521231be5e/40273_2022_1208_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcd/9928797/644a7f12f852/40273_2022_1208_Fig4_HTML.jpg

相似文献

[1]
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned.

Pharmacoeconomics. 2023-3

[2]
Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.

Health Qual Life Outcomes. 2017-2-20

[3]
The EQ-5D-5L Valuation Study in Egypt.

Pharmacoeconomics. 2022-4

[4]
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration.

Soc Sci Med. 2022-1

[5]
Quality Control Process for EQ-5D-5L Valuation Studies.

Value Health. 2017-3

[6]
EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.

BMJ Open. 2021-12-23

[7]
Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states.

Eur J Health Econ. 2024-9

[8]
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.

Value Health. 2016

[9]
The EQ-5D-5L Valuation Study in Egypt.

Pharmacoeconomics. 2021-5

[10]
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Qual Life Res. 2019-6-14

引用本文的文献

[1]
The EQ-5D-5L valuation study for Trinidad and Tobago.

Health Qual Life Outcomes. 2024-7-2

本文引用的文献

[1]
Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study.

Patient. 2022-9

[2]
EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.

BMJ Open. 2021-12-23

[3]
The EQ-5D-5L Valuation Study in Egypt.

Pharmacoeconomics. 2022-4

[4]
Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.

Value Health. 2020-7-18

[5]
An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.

Expert Rev Pharmacoecon Outcomes Res. 2020-8

[6]
A French Value Set for the EQ-5D-5L.

Pharmacoeconomics. 2020-4

[7]
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.

Value Health. 2019-1-2

[8]
Valuation of the EQ-5D-5L in Taiwan.

PLoS One. 2018-12-26

[9]
The EQ-5D-5L Valuation study in Thailand.

Expert Rev Pharmacoecon Outcomes Res. 2018-10

[10]
Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?

PLoS One. 2017-9-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索